Kestrel

In-Vitro Diagnostics, Point of Care Testing & Pathology Services Project_1717

Supply Chain Coordination Limited · published Wed 28 Oct 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by Aquilant Limited and Central Medical Supplies Limited and GBUK Ltd and 31 more in Oct 2026, for £1.4bn.

What you're up against

  • The same firms have won it the last 3 times Kestrel found: expect them to bid again, and to know the work well.
  • 54 different firms won this buyer's 3 awards for this kind of work in 2026.
  • It last went for £1440m in 2026.
  • The last award named 34 suppliers: it may be a framework, where many firms are chosen.

From Supply Chain Coordination Limited's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The documents are on Jaggaer, where the bid is sent too. It's free to register there.

The notice as published

NHS Supply Chain intends to launch a National Framework Agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products & Related Pathology Services, this will include: - Pathology Managed Services - Reagent Rental Agreements - Pathology Software - Core Laboratory Equipment, Instruments & Consumables, to cover all pathology disciplines such as but not limited to Biochemistry, Microbiology, Immunology, Cellular Pathology, Virology, Haematology, Genomics & Molecular Testing and Reproductive Sciences - Point of Care Testing - Specimen Collection - Specimen Storage This Lot seeks Managed Service (MS) solutions that delivers end-to-end pathology and POCT outcomes (preanalytical > analytical > postanalytical) with assured quality, resilient capacity, and measurable operational/clinical impact, while enabling the expansion of diagnostics into Community Diagnostic Centres (CDCs) and neighbourhood/community settings consistent with the NHS 10 Year Plan’s shift hospital > community; analogue > digital; sickness > prevention. This Lot seeks to enable the procurement of IT Solutions that include but are not limited to Software, Middleware, Artificial Intelligence (AI) platforms, that will offer support in: • Clinical laboratory workflows • Diagnostic processing & Reporting • Sample Tracking & Archiving Solutions • Data interoperability across systems • Long term sample archiving • Specimen analysis and management • Integration with laboratory hardware • Modernisation & Transformation solutions • Laboratory Monitoring Solutions This Lot seeks solutions that deliver safe, reliable, efficient and interoperable diagnostic outcomes across all pathology disciplines, NHS Screening Programmes and diagnostic care settings. Solutions may support the delivery of diagnostic services within laboratory environments, point of care settings, community diagnostic services and home/self-testing pathways whilst maintaining appropriate clinical performance, quality assurance, governance, interoperability and patient safety requirements. Solutions offered may support including but not limited to: • Blood Sciences (Haematology, Coagulation, Clinical Chemistry, Immunoassay, Toxicology, Transfusion & Transplantation Support) • Cellular Pathology (Histology, Cytology, Immunohistochemistry, In Situ Hybridisation) • Microbiology, Virology & Serology • Transfusion & Transplantation Support • Genomics & Molecular Diagnostics • Digital Pathology & Imaging • Reproductive Sciences (Andrology & Fertility Diagnostics) • Specimen Collection • Specimen Storage • Supportive Laboratory Infrastructure (Autopsy/Mortuary, Workflow Tools) • Research and Development Products